Physician profile
Thomas Leach
NPI 1114089141
$1,008.87
in general payments reported to CMS, 2019-2025
7 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.13 · 2021: $14.38 · 2022: $130 · 2023: $34.63 · 2024: $595 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $778 · Travel and Lodging: $35.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.13 |
| Travel and Lodging | $35.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $579.92 | 2024 | |
| Solventum Corporation | $156.48 | 2025 | Prevena, V.A.C.Ulta |
| Allergan, INC. | $140.59 | 2019-2022 | |
| Mentor Worldwide LLC | $43.90 | 2021-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Smith+Nephew, INC. | $40.21 | 2019 | |
| Motiva USA, LLC | $27.43 | 2025 | |
| Integra Lifesciences Corporation | $20.34 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Leach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.